Global Diabetic Neuropathy Treatment Market Research Report 2023

Report ID: 1982635 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetic Neuropathy Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Peripheral Neuropathy
        1.2.3 Autonomic Neuropathy
        1.2.4 Proximal Neuropathy
        1.2.5 Focal Neuropathy
    1.3 Market by Application
        1.3.1 Global Diabetic Neuropathy Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Diabetic Neuropathy Treatment Market Perspective (2017-2028)
    2.2 Diabetic Neuropathy Treatment Growth Trends by Region
        2.2.1 Diabetic Neuropathy Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Diabetic Neuropathy Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Diabetic Neuropathy Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Diabetic Neuropathy Treatment Market Dynamics
        2.3.1 Diabetic Neuropathy Treatment Industry Trends
        2.3.2 Diabetic Neuropathy Treatment Market Drivers
        2.3.3 Diabetic Neuropathy Treatment Market Challenges
        2.3.4 Diabetic Neuropathy Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Diabetic Neuropathy Treatment Players by Revenue
        3.1.1 Global Top Diabetic Neuropathy Treatment Players by Revenue (2017-2022)
        3.1.2 Global Diabetic Neuropathy Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Diabetic Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Diabetic Neuropathy Treatment Revenue
    3.4 Global Diabetic Neuropathy Treatment Market Concentration Ratio
        3.4.1 Global Diabetic Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neuropathy Treatment Revenue in 2021
    3.5 Diabetic Neuropathy Treatment Key Players Head office and Area Served
    3.6 Key Players Diabetic Neuropathy Treatment Product Solution and Service
    3.7 Date of Enter into Diabetic Neuropathy Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Neuropathy Treatment Breakdown Data by Type
    4.1 Global Diabetic Neuropathy Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Diabetic Neuropathy Treatment Forecasted Market Size by Type (2023-2028)
5 Diabetic Neuropathy Treatment Breakdown Data by Application
    5.1 Global Diabetic Neuropathy Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Diabetic Neuropathy Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Diabetic Neuropathy Treatment Market Size (2017-2028)
    6.2 North America Diabetic Neuropathy Treatment Market Size by Country (2017-2022)
    6.3 North America Diabetic Neuropathy Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Diabetic Neuropathy Treatment Market Size (2017-2028)
    7.2 Europe Diabetic Neuropathy Treatment Market Size by Country (2017-2022)
    7.3 Europe Diabetic Neuropathy Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Diabetic Neuropathy Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Diabetic Neuropathy Treatment Market Size (2017-2028)
    9.2 Latin America Diabetic Neuropathy Treatment Market Size by Country (2017-2022)
    9.3 Latin America Diabetic Neuropathy Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Diabetic Neuropathy Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Diabetic Neuropathy Treatment Introduction
        11.1.4 Abbott Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Diabetic Neuropathy Treatment Introduction
        11.2.4 Roche Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.2.5 Roche Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Detail
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Diabetic Neuropathy Treatment Introduction
        11.3.4 Eli Lilly Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.3.5 Eli Lilly Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Diabetic Neuropathy Treatment Introduction
        11.4.4 Johnson & Johnson Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Detail
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Diabetic Neuropathy Treatment Introduction
        11.5.4 GlaxoSmithKline Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Development
    11.6 Lupin
        11.6.1 Lupin Company Detail
        11.6.2 Lupin Business Overview
        11.6.3 Lupin Diabetic Neuropathy Treatment Introduction
        11.6.4 Lupin Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.6.5 Lupin Recent Development
    11.7 Glenmark
        11.7.1 Glenmark Company Detail
        11.7.2 Glenmark Business Overview
        11.7.3 Glenmark Diabetic Neuropathy Treatment Introduction
        11.7.4 Glenmark Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.7.5 Glenmark Recent Development
    11.8 Depomed
        11.8.1 Depomed Company Detail
        11.8.2 Depomed Business Overview
        11.8.3 Depomed Diabetic Neuropathy Treatment Introduction
        11.8.4 Depomed Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.8.5 Depomed Recent Development
    11.9 Astellas
        11.9.1 Astellas Company Detail
        11.9.2 Astellas Business Overview
        11.9.3 Astellas Diabetic Neuropathy Treatment Introduction
        11.9.4 Astellas Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.9.5 Astellas Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Detail
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Diabetic Neuropathy Treatment Introduction
        11.10.4 Pfizer Revenue in Diabetic Neuropathy Treatment Business (2017-2022)
        11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Diabetic Neuropathy Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Peripheral Neuropathy
    Table 3. Key Players of Autonomic Neuropathy
    Table 4. Key Players of Proximal Neuropathy
    Table 5. Key Players of Focal Neuropathy
    Table 6. Global Diabetic Neuropathy Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Diabetic Neuropathy Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Diabetic Neuropathy Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Diabetic Neuropathy Treatment Market Share by Region (2017-2022)
    Table 10. Global Diabetic Neuropathy Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Diabetic Neuropathy Treatment Market Share by Region (2023-2028)
    Table 12. Diabetic Neuropathy Treatment Market Trends
    Table 13. Diabetic Neuropathy Treatment Market Drivers
    Table 14. Diabetic Neuropathy Treatment Market Challenges
    Table 15. Diabetic Neuropathy Treatment Market Restraints
    Table 16. Global Diabetic Neuropathy Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Diabetic Neuropathy Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Diabetic Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neuropathy Treatment as of 2021)
    Table 19. Ranking of Global Top Diabetic Neuropathy Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Diabetic Neuropathy Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Diabetic Neuropathy Treatment Product Solution and Service
    Table 23. Date of Enter into Diabetic Neuropathy Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Diabetic Neuropathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Diabetic Neuropathy Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Diabetic Neuropathy Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Diabetic Neuropathy Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Diabetic Neuropathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Diabetic Neuropathy Treatment Revenue Market Share by Application (2017-2022)
    Table 31. Global Diabetic Neuropathy Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Diabetic Neuropathy Treatment Revenue Market Share by Application (2023-2028)
    Table 33. North America Diabetic Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Diabetic Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Diabetic Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Diabetic Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Diabetic Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Diabetic Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Abbott Company Detail
    Table 44. Abbott Business Overview
    Table 45. Abbott Diabetic Neuropathy Treatment Product
    Table 46. Abbott Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 47. Abbott Recent Development
    Table 48. Roche Company Detail
    Table 49. Roche Business Overview
    Table 50. Roche Diabetic Neuropathy Treatment Product
    Table 51. Roche Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 52. Roche Recent Development
    Table 53. Eli Lilly Company Detail
    Table 54. Eli Lilly Business Overview
    Table 55. Eli Lilly Diabetic Neuropathy Treatment Product
    Table 56. Eli Lilly Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 57. Eli Lilly Recent Development
    Table 58. Johnson & Johnson Company Detail
    Table 59. Johnson & Johnson Business Overview
    Table 60. Johnson & Johnson Diabetic Neuropathy Treatment Product
    Table 61. Johnson & Johnson Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 62. Johnson & Johnson Recent Development
    Table 63. GlaxoSmithKline Company Detail
    Table 64. GlaxoSmithKline Business Overview
    Table 65. GlaxoSmithKline Diabetic Neuropathy Treatment Product
    Table 66. GlaxoSmithKline Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 67. GlaxoSmithKline Recent Development
    Table 68. Lupin Company Detail
    Table 69. Lupin Business Overview
    Table 70. Lupin Diabetic Neuropathy Treatment Product
    Table 71. Lupin Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 72. Lupin Recent Development
    Table 73. Glenmark Company Detail
    Table 74. Glenmark Business Overview
    Table 75. Glenmark Diabetic Neuropathy Treatment Product
    Table 76. Glenmark Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 77. Glenmark Recent Development
    Table 78. Depomed Company Detail
    Table 79. Depomed Business Overview
    Table 80. Depomed Diabetic Neuropathy Treatment Product
    Table 81. Depomed Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 82. Depomed Recent Development
    Table 83. Astellas Company Detail
    Table 84. Astellas Business Overview
    Table 85. Astellas Diabetic Neuropathy Treatment Product
    Table 86. Astellas Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 87. Astellas Recent Development
    Table 88. Pfizer Company Detail
    Table 89. Pfizer Business Overview
    Table 90. Pfizer Diabetic Neuropathy Treatment Product
    Table 91. Pfizer Revenue in Diabetic Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 92. Pfizer Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetic Neuropathy Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Peripheral Neuropathy Features
    Figure 3. Autonomic Neuropathy Features
    Figure 4. Proximal Neuropathy Features
    Figure 5. Focal Neuropathy Features
    Figure 6. Global Diabetic Neuropathy Treatment Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Diabetic Neuropathy Treatment Report Years Considered
    Figure 11. Global Diabetic Neuropathy Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Diabetic Neuropathy Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Diabetic Neuropathy Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Diabetic Neuropathy Treatment Market Share by Players in 2021
    Figure 15. Global Top Diabetic Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neuropathy Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Diabetic Neuropathy Treatment Revenue in 2021
    Figure 17. North America Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Diabetic Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 19. United States Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Diabetic Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 23. Germany Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Diabetic Neuropathy Treatment Market Share by Region (2017-2028)
    Figure 31. China Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Diabetic Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 39. Mexico Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Diabetic Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 43. Turkey Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Diabetic Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Abbott Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 47. Eli Lilly Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 49. GlaxoSmithKline Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 50. Lupin Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 51. Glenmark Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 52. Depomed Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 53. Astellas Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 54. Pfizer Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Lupin
Glenmark
Depomed
Astellas
Pfizer
Frequently Asked Questions
Diabetic Neuropathy Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetic Neuropathy Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetic Neuropathy Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Diagnostic Enzymes

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Dialer

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Diclofenac

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Die Cutting Machine

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More